MedPath

IV Acetaminophen for Postoperative Analgesia

Phase 4
Terminated
Conditions
Postoperative Pain
Postoperative Nausea
Postoperative Vomiting
Interventions
Drug: Standard of Care
Registration Number
NCT01798316
Lead Sponsor
Northwell Health
Brief Summary

The purpose of this study is to evaluate the use of IV acetaminophen for postoperative pain management after laparoscopic cholecystectomy to determine if its use to supplement standard of care pain management decreases the incidence of post-operative nausea and vomiting.

Detailed Description

The recent clinical development of an intravenous (IV) acetaminophen formulation for use in the US has important implications for the management of postoperative pain given its safety profile and suitability for use in the early phase of the postoperative period. In clinical studies a significant opioid-sparing effect has been documented with a substantial percentage of patients avoiding the need for opioid rescue medication altogether. This avoidance or delay in the use of opioids has been shown to reduce undesirable side effects. It is proposed that the use of IV acetaminophen in the post anesthesia care unit (PACU) for postoperative analgesia after laparoscopic cholecystectomy will result in decreased incidence of post operative nausea and vomiting (PONV) and decreased use of narcotics.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
105
Inclusion Criteria
  • Subject is undergoing pre-scheduled laparoscopic cholecystectomy;
  • American Society of Anesthesiology patient classification status I-II
Exclusion Criteria
  • Regular preoperative use of or opioids,
  • Subjects admitted after surgery for postoperative complications other than postoperative pain or PONV.
  • Subjects converted to open laparoscopic cholecystectomy
  • Known allergy/hypersensitivity to acetaminophen
  • Use of opioids prior to commencement of the study (<7 days)
  • Patients with chronic pain conditions or disease requiring pain control
  • Abnormal liver function
  • Known or suspected alcohol, drug or opiate abuse or dependence
  • Patients with a BMI of greater than 35
  • Other physical, mental or medical conditions that could effect participation.
  • Abnormal renal function; serum creatinine>2gm/dl

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
IV AcetaminophenIV AcetaminophenIV Acetaminophen administered on admission to post-anesthesia care unit
Standard of careStandard of CareStandard of care pain management regimen including opioids administered on admission to post-anesthesia care unit
Primary Outcome Measures
NameTimeMethod
Number of Participants With Postoperative Nausea and Vomiting (PONV).4 hours plus/minus 30 minutes

Number of participants with postoperative nausea and vomiting (PONV) will be recorded during PACU stay.

PONV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching.

Secondary Outcome Measures
NameTimeMethod
Number of Participants With Post Discharge Nausea and Vomiting (PDNV)Up to two days following surgery

Number of participants reporting post discharge nausea and vomiting (PDNV) documented up to 2 days following surgery.

PDNV is defined as nausea intensity of 4 or higher on 0-10 numeric rating scale (NRS) and/or at least one episode of vomiting/retching following discharge.

Highest Pain Intensity Score Using Numeric Rating Scale (NRS)4 hours plus/minus 30 minutes

Highest pain intensity reported during PACU stay using a 11-point (0-10) pain intensity numeric rating scale (NRS). Higher values represent higher pain intensities.

Patient Satisfaction on a 5 Point Likert ScaleUp to one week following surgery

Number of patients very satisfied or satisfied with pain and PONV management during hospital stay

Pain Intensity Score 1 Hour Following Surgery Using Numeric Rating Scale1 hour following surgery

Pain intensity score reported by participants 1 hour following surgery using an 11-point, 0-10 Numeric Rating Scale (NRS). Higher scores indicate higher pain intensities

Trial Locations

Locations (3)

Long Island Jewish Medical Center

🇺🇸

New Hyde Park, New York, United States

Syosset Hospital

🇺🇸

Syosset, New York, United States

North Shore University Hospital

🇺🇸

Manhasset, New York, United States

© Copyright 2025. All Rights Reserved by MedPath